MiRNAs Predict the Prognosis of Patients With Triple Negative Breast Cancer: A Meta-Analysis

PLoS ONE - United States
doi 10.1371/journal.pone.0170088
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis

Frontiers in Oncology
Cancer ResearchOncology
2019English

Identification of Prognosis-Relevant Subgroups in Patients With Chemoresistant Triple-Negative Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2013English

Accumulation of P62 Is Associated With Poor Prognosis in Patients With Triple-Negative Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2013English

Platinum-Based Therapy for Triple-Negative Breast Cancer Treatment: A Meta-Analysis

Molecular and Clinical Oncology
Cancer ResearchOncology
2015English

T‑cadherin Is Associated With Prognosis in Triple‑negative Breast Cancer

Oncology Letters
Cancer ResearchOncology
2017English

Prognostic Value of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Integrative Analysis of lncRNAs and miRNAs With Coding RNAs Associated With ceRNA Crosstalk Network in Triple Negative Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2017English

Triple-Negative Breast Cancer

2018English

Expression of Dickkopf-1 and Beta-Catenin Related to the Prognosis of Breast Cancer Patients With Triple Negative Phenotype

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy